Error in Byline - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: Inaccurate Author Credentials in the Study on Oral Anticoagulants for Atrial Fibrillation Patients with Advanced CKD Not Undergoing Dialysis

  • October 6, 2026

Share

Clinical Scorecard: Correction Notice: Inaccurate Author Credentials in the Study on Oral Anticoagulants for Atrial Fibrillation Patients with Advanced CKD Not Undergoing Dialysis

At a Glance

CategoryDetail
ConditionAtrial Fibrillation and Advanced CKD
Key MechanismsOral Anticoagulants
Target PopulationPatients with Atrial Fibrillation and Advanced CKD Not Undergoing Dialysis
Care SettingClinical Research

Key Highlights

  • Correction of author credentials in the original study
  • Authors' degrees corrected to PhDs
  • Original investigation published on September 4, 2026

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with Atrial Fibrillation and Advanced CKD Not Undergoing Dialysis

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Error in Byline

            • October 6, 2026

            Related Content

            Transradial Endovascular Treatment of Acute External Iliac Artery Rupture in Hemorrhagic Shock

            When Do Vascular Surgeons Need to Think Outside of the Box?

            A Keck Medicine of USC expert explains how vascular surgeons innovate to treat complicated cases.

            • by

            • October 6, 2026

            • 6 min
            FDA updates PAH label with trial data

            In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.